卵清蛋白
免疫系统
佐剂
抗原
癌症研究
交叉展示
免疫疗法
刺
细胞毒性T细胞
免疫增强剂
癌症免疫疗法
干扰素基因刺激剂
化学
抗原呈递
生物
免疫学
T细胞
先天免疫系统
生物化学
体外
航空航天工程
工程类
作者
Yilei Zhao,Ruinan Song,Zhen Zhang,Houyang Hu,Wenli Ning,Xiuying Duan,Jianwei Jiao,Xiao Fu,Guiqiang Zhang
出处
期刊:Nanoscale advances
[Royal Society of Chemistry]
日期:2023-12-08
卷期号:6 (1): 72-78
被引量:10
摘要
Nanovaccines have emerged as promising agents for cancer therapy because of their ability to induce specific immune responses without off-target effects. However, inadequate cytotoxic T lymphocyte response and low antigen/adjuvant encapsulation remain major obstacles to vaccinating against cancer. Herein, we designed a stimulator of interferon genes (STING) pathway-activating nanovaccine based on hollow metal-organic frameworks (MOFs) for tumor treatment. The nanovaccine (OVA@HZIF-Mn) was constructed by encapsulating a model antigen ovalbumin (OVA) into zeolitic imidazolate framework-8, followed by etching with tannic acid and functionalizing with manganese ions. Studies have shown that the nanovaccine can effectively enhance antigen uptake, STING pathway activation and dendritic cell maturation, triggering a robust immune response to inhibit tumor growth. In addition, no infection or pathological signs were observed in mice organs after multiple administrations. This study combines a simple assembly approach and superior therapeutic effect, providing a promising strategy for engineering effective nanovaccines.
科研通智能强力驱动
Strongly Powered by AbleSci AI